Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

New Avenues for Parkinson’s Disease Therapeutics: Disease-Modifying Strategies Based on the Gut Microbiota
Marina Lorente Picón, Ariadna Laguna
Biomolecules (2021) Vol. 11, Iss. 3, pp. 433-433
Open Access | Times Cited: 51

Showing 1-25 of 51 citing articles:

The role of microbiota-gut-brain axis in neuropsychiatric and neurological disorders
Katarzyna Socała, Urszula Doboszewska, Aleksandra Szopa, et al.
Pharmacological Research (2021) Vol. 172, pp. 105840-105840
Open Access | Times Cited: 452
A Comprehensive Review on the Role of the Gut Microbiome in Human Neurological Disorders
Shokufeh Ghasemian Sorboni, Hanieh Shakeri Moghaddam, Reza Jafarzadeh Esfehani, et al.
Clinical Microbiology Reviews (2022) Vol. 35, Iss. 1
Open Access | Times Cited: 274
Therapeutic Benefits and Dietary Restrictions of Fiber Intake: A State of the Art Review
Corina-Bianca Ioniță-Mîndrican, Khaled Ziani, Magdalena Mititelu, et al.
Nutrients (2022) Vol. 14, Iss. 13, pp. 2641-2641
Open Access | Times Cited: 132
Gut Microbiota: A Novel Therapeutic Target for Parkinson’s Disease
Manlian Zhu, Xia Liu, Yiru Ye, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 97
New era of artificial intelligence and machine learning-based detection, diagnosis, and therapeutics in Parkinson’s disease
Rohan Gupta, Smita Kumari, Anusha Senapati, et al.
Ageing Research Reviews (2023) Vol. 90, pp. 102013-102013
Closed Access | Times Cited: 49
Fecal microbiota transplant as a potential treatment for Parkinson's disease – A case series
Arik Segal, Yair Zlotnik, Keren Moyal-Atias, et al.
Clinical Neurology and Neurosurgery (2021) Vol. 207, pp. 106791-106791
Closed Access | Times Cited: 87
Pyrroloquinoline-Quinone Is More Than an Antioxidant: A Vitamin-like Accessory Factor Important in Health and Disease Prevention
Karen R. Jonscher, Winyoo Chowanadisai, Robert B. Rucker
Biomolecules (2021) Vol. 11, Iss. 10, pp. 1441-1441
Open Access | Times Cited: 56
The Interplay between Gut Microbiota and Parkinson’s Disease: Implications on Diagnosis and Treatment
Angelica Varesi, Lucrezia Irene Maria Campagnoli, Foroogh Fahmideh, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 20, pp. 12289-12289
Open Access | Times Cited: 44
Parkinson’s disease and gut microbiota: from clinical to mechanistic and therapeutic studies
Xuxiang Zhang, Beisha Tang, Jifeng Guo
Translational Neurodegeneration (2023) Vol. 12, Iss. 1
Open Access | Times Cited: 34
Probiotics for Neurodegenerative Diseases: A Systemic Review
Sandhya Ojha, Nil Patil, Mukul Jain, et al.
Microorganisms (2023) Vol. 11, Iss. 4, pp. 1083-1083
Open Access | Times Cited: 31
Sodium butyrate ameliorates gut dysfunction and motor deficits in a mouse model of Parkinson’s disease by regulating gut microbiota
Yi Zhang, Shaoqing Xu, Yiwei Qian, et al.
Frontiers in Aging Neuroscience (2023) Vol. 15
Open Access | Times Cited: 24
EXPLORING THE MICROBIOTA-INTESTINE-BRAIN AXIS IN PARKINSON'S DISEASE AND THE POTENTIAL OF FECAL MICROBIOTA TRANSPLANTATION (FMT) THERAPY
Mariana Yukari Aguena, Atsushi Ogata, José Baptista, et al.
International Journal of Health Science (2025) Vol. 5, Iss. 5, pp. 1-6
Closed Access
Future prospective of microbiome-gut brain axis for treatment of CNS disorders
Ramdas Mane, Saurabh Kashid, Farhan Mazahir, et al.
Elsevier eBooks (2025), pp. 441-478
Closed Access
Mediterranean Diet and Parkinson’s Disease
Marco Bisaglia
International Journal of Molecular Sciences (2022) Vol. 24, Iss. 1, pp. 42-42
Open Access | Times Cited: 31
The brain-gut-microbiota axis in the treatment of neurologic and psychiatric disorders
Maria Fernanda Naufel, Giselle Truzzi, Caroline M. Ferreira, et al.
Arquivos de Neuro-Psiquiatria (2023) Vol. 81, Iss. 07, pp. 670-684
Open Access | Times Cited: 15
Synergistic Welfare of Synbiotic Nutraceuticals on Neurological Function
Asif Ahmad Bhat, Ritu Gilhotra, Riya Thapa, et al.
(2024), pp. 571-580
Closed Access | Times Cited: 5
Crosstalk Between Intestinal Serotonergic System and Pattern Recognition Receptors on the Microbiota–Gut–Brain Axis
Elena Layunta, Berta Buey, José Emilio Mesonero, et al.
Frontiers in Endocrinology (2021) Vol. 12
Open Access | Times Cited: 32
Inflammatory microbes and genes as potential biomarkers of Parkinson’s disease
Shiqing Nie, Jichen Wang, Ye Deng, et al.
npj Biofilms and Microbiomes (2022) Vol. 8, Iss. 1
Open Access | Times Cited: 25
DNA Methylation Signature of Aging: Potential Impact on the Pathogenesis of Parkinson’s Disease
Volkan Yazar, Valina L. Dawson, Ted M. Dawson, et al.
Journal of Parkinson s Disease (2023) Vol. 13, Iss. 2, pp. 145-164
Open Access | Times Cited: 12
Pathways to healing: Plants with therapeutic potential for neurodegenerative diseases
Sheena E.B. Tyler, Luke D.K. Tyler
IBRO Neuroscience Reports (2023) Vol. 14, pp. 210-234
Open Access | Times Cited: 12
Bioengineered 3D Tissue Model of Intestine Epithelium with Oxygen Gradients to Sustain Human Gut Microbiome
Ying Chen, Sara Rudolph, Brooke N. Longo, et al.
Advanced Healthcare Materials (2022) Vol. 11, Iss. 16
Open Access | Times Cited: 19
A new paradigm for a new simple chemical: butyrate & immune regulation
Guoqi Dang, Weida Wu, Hongfu Zhang, et al.
Food & Function (2021) Vol. 12, Iss. 24, pp. 12181-12193
Open Access | Times Cited: 24
Current understanding of the human microbiome in glioma
Jianhao Liang, Ting Li, Jiajia Zhao, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 15
Gut brain axis: an insight into microbiota role in Parkinson’s disease
Sara A. Moustafa, Shrouk M. Abdou, Abdelhameed Dawood, et al.
Metabolic Brain Disease (2021) Vol. 36, Iss. 7, pp. 1545-1557
Closed Access | Times Cited: 17
Intestinal Dopamine Receptor D2 is Required for Neuroprotection Against 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced Dopaminergic Neurodegeneration
Hai-Rong Peng, Shui Yu, Yukai Zhang, et al.
Neuroscience Bulletin (2022) Vol. 38, Iss. 8, pp. 871-886
Open Access | Times Cited: 12
Page 1 - Next Page

Scroll to top